Your browser doesn't support javascript.
loading
Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions.
Mendes-Bastos, Pedro; Brasileiro, Ana; Kolkhir, Pavel; Frischbutter, Stefan; Scheffel, Jörg; Moñino-Romero, Sherezade; Maurer, Marcus.
Afiliação
  • Mendes-Bastos P; Dermatology Center, Hospital CUF Descobertas, Lisbon, Portugal.
  • Brasileiro A; Department of Dermatology, Hospital Santo António dos Capuchos, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
  • Kolkhir P; NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal.
  • Frischbutter S; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Scheffel J; Division of Immune-Mediated Skin Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Moñino-Romero S; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Maurer M; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Allergy ; 77(8): 2355-2366, 2022 08.
Article em En | MEDLINE | ID: mdl-35175630
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pênfigo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pênfigo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article